Literature DB >> 15041525

Methodological issues in cross-cultural and multicultural rorschach research.

James Allen1, Richard H Dana.   

Abstract

Hermann Rorschach researched the utility of his inkblot experiment to understand psychopathology and cultural differences. Contemporary research with the Rorschach has evaluated its utility as a test, although it may more properly represent a clinical method with somewhat different evaluation criteria. Recent controversy regarding the adequacy of the Rorschach as a test and the adequacy of its normative data has at times distorted and oversimplified important methodological issues inherent in the study of cultural difference. Cultural processes remain a central and inadequately examined variable in Rorschach research; an important emergent area of inquiry is the Rorschach's clinical utility as a cross-cultural assessment instrument. We review multicultural and cross-cultural methodological issues intrinsic to contemporary Rorschach research here. Consideration of cultural issues enlarges and enriches the Rorschach clinical utility debate and suggests underexplored research strategies that can contribute to its resolution.

Mesh:

Year:  2004        PMID: 15041525     DOI: 10.1207/s15327752jpa8202_7

Source DB:  PubMed          Journal:  J Pers Assess        ISSN: 0022-3891


  3 in total

1.  Norms of the Rorschach Test for Indian Subjects.

Authors:  S Chaudhury; M Augustine; D Saldanha; K Srivastava; S M Kundeyawala; A A Pawar; Vssr Ryali
Journal:  Med J Armed Forces India       Date:  2011-07-21

2.  Distinctive Rorschach profiles of young adults with schizophrenia and autism spectrum disorder.

Authors:  Naoko Kishimoto; Kazuhiko Yamamuro; Junzo Iida; Toyosaku Ota; Shohei Tanaka; Masanori Kyo; Sohei Kimoto; Toshifumi Kishimoto
Journal:  Neuropsychiatr Dis Treat       Date:  2016-09-21       Impact factor: 2.570

3.  Relationship of Pretreatment Rorschach Factors to Symptoms, Quality of Life, and Real-Life Functioning in a 3-Year Follow-Up of Traumatized Refugee Patients.

Authors:  Marianne Opaas; Ellen Hartmann; Tore Wentzel-Larsen; Sverre Varvin
Journal:  J Pers Assess       Date:  2015-11-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.